APA

Ring E. K., Li R., Moore B. P., Nan L., Kelly V. M., Han X., Beierle E. A., Markert J. M., Leavenworth J. W., Gillespie G. Y. & Friedman G. K. (2017). Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. : Molecular therapy oncolytics.

Chicago

Ring Eric K, Li Rong, Moore Blake P, Nan Li, Kelly Virginia M, Han Xiaosi, Beierle Elizabeth A, Markert James M, Leavenworth Jianmei W, Gillespie G Yancey and Friedman Gregory K. 2017. Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. : Molecular therapy oncolytics.

Harvard

Ring E. K., Li R., Moore B. P., Nan L., Kelly V. M., Han X., Beierle E. A., Markert J. M., Leavenworth J. W., Gillespie G. Y. and Friedman G. K. (2017). Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. : Molecular therapy oncolytics.

MLA

Ring Eric K, Li Rong, Moore Blake P, Nan Li, Kelly Virginia M, Han Xiaosi, Beierle Elizabeth A, Markert James M, Leavenworth Jianmei W, Gillespie G Yancey and Friedman Gregory K. Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. : Molecular therapy oncolytics. 2017.